100 related articles for article (PubMed ID: 31702518)
1. Phospholipase Cγ Signaling in Bone Marrow Stem Cell and Relevant Natural Compounds Therapy.
Liu C; He Y; Xu X; He B
Curr Stem Cell Res Ther; 2020; 15(7):579-587. PubMed ID: 31702518
[TBL] [Abstract][Full Text] [Related]
2. Oleanolic acid acetate inhibits osteoclast differentiation by downregulating PLCγ2-Ca(2+)-NFATc1 signaling, and suppresses bone loss in mice.
Kim JY; Cheon YH; Oh HM; Rho MC; Erkhembaatar M; Kim MS; Lee CH; Kim JJ; Choi MK; Yoon KH; Lee MS; Oh J
Bone; 2014 Mar; 60():104-11. PubMed ID: 24361669
[TBL] [Abstract][Full Text] [Related]
3. Phospholipase Cγ1 (PLCγ1) Controls Osteoclast Numbers via Colony-stimulating Factor 1 (CSF-1)-dependent Diacylglycerol/β-Catenin/CyclinD1 Pathway.
Yang Z; Kim S; Mahajan S; Zamani A; Faccio R
J Biol Chem; 2017 Jan; 292(4):1178-1186. PubMed ID: 27941021
[TBL] [Abstract][Full Text] [Related]
4. PLCgamma2 regulates osteoclastogenesis via its interaction with ITAM proteins and GAB2.
Mao D; Epple H; Uthgenannt B; Novack DV; Faccio R
J Clin Invest; 2006 Nov; 116(11):2869-79. PubMed ID: 17053833
[TBL] [Abstract][Full Text] [Related]
5. VapB as a regulator of osteoclastogenesis via modulation of PLCγ2-Ca(2+)-NFAT signaling.
Choi SW; Yeon JT; Park KI; Lee CH; Youn BS; Oh J; Lee MS
FEBS Lett; 2012 Feb; 586(3):263-9. PubMed ID: 22245675
[TBL] [Abstract][Full Text] [Related]
6. Artesunate suppresses RANKL-induced osteoclastogenesis through inhibition of PLCγ1-Ca
Zeng X; Zhang Y; Wang S; Wang K; Tao L; Zou M; Chen N; Xu J; Liu S; Li X
Biochem Pharmacol; 2017 Jan; 124():57-68. PubMed ID: 27789216
[TBL] [Abstract][Full Text] [Related]
7. Trapidil, a platelet-derived growth factor antagonist, inhibits osteoclastogenesis by down-regulating NFATc1 and suppresses bone loss in mice.
Kim SD; Kim HN; Lee JH; Jin WJ; Hwang SJ; Kim HH; Ha H; Lee ZH
Biochem Pharmacol; 2013 Sep; 86(6):782-90. PubMed ID: 23928189
[TBL] [Abstract][Full Text] [Related]
8. RGS10-null mutation impairs osteoclast differentiation resulting from the loss of [Ca2+]i oscillation regulation.
Yang S; Li YP
Genes Dev; 2007 Jul; 21(14):1803-16. PubMed ID: 17626792
[TBL] [Abstract][Full Text] [Related]
9. Methyl Gallate Inhibits Osteoclast Formation and Function by Suppressing Akt and Btk-PLCγ2-Ca
Baek JM; Kim JY; Lee CH; Yoon KH; Lee MS
Int J Mol Sci; 2017 Mar; 18(3):. PubMed ID: 28272351
[TBL] [Abstract][Full Text] [Related]
10. Sophorae Flos extract inhibits RANKL-induced osteoclast differentiation by suppressing the NF-κB/NFATc1 pathway in mouse bone marrow cells.
Kim JM; Lee JH; Lee GS; Noh EM; Song HK; Gu DR; Kim SC; Lee SH; Kwon KB; Lee YR
BMC Complement Altern Med; 2017 Mar; 17(1):164. PubMed ID: 28335757
[TBL] [Abstract][Full Text] [Related]
11. SH2 domain-mediated activation of phospholipase Cgamma is not required to initiate Ca2+ release at fertilization of mouse eggs.
Mehlmann LM; Carpenter G; Rhee SG; Jaffe LA
Dev Biol; 1998 Nov; 203(1):221-32. PubMed ID: 9806786
[TBL] [Abstract][Full Text] [Related]
12. CTRP3 acts as a negative regulator of osteoclastogenesis through AMPK-c-Fos-NFATc1 signaling in vitro and RANKL-induced calvarial bone destruction in vivo.
Kim JY; Min JY; Baek JM; Ahn SJ; Jun HY; Yoon KH; Choi MK; Lee MS; Oh J
Bone; 2015 Oct; 79():242-51. PubMed ID: 26103094
[TBL] [Abstract][Full Text] [Related]
13. Activation of dimeric glucocorticoid receptors in osteoclast progenitors potentiates RANKL induced mature osteoclast bone resorbing activity.
Conaway HH; Henning P; Lie A; Tuckermann J; Lerner UH
Bone; 2016 Dec; 93():43-54. PubMed ID: 27596806
[TBL] [Abstract][Full Text] [Related]
14. Mechanistic insight into osteoclast differentiation in osteoimmunology.
Takayanagi H
J Mol Med (Berl); 2005 Mar; 83(3):170-9. PubMed ID: 15776286
[TBL] [Abstract][Full Text] [Related]
15. Docosahexaenoic acid signaling attenuates the proliferation and differentiation of bone marrow-derived osteoclast precursors and promotes apoptosis in mature osteoclasts.
Kim HJ; Ohk B; Yoon HJ; Kang WY; Seong SJ; Kim SY; Yoon YR
Cell Signal; 2017 Jan; 29():226-232. PubMed ID: 27836739
[TBL] [Abstract][Full Text] [Related]
16. Role of ANTXR1 in the regulation of RANKL-induced osteoclast differentiation and function.
Baek JM; Kwak SC; Yoon KH; Kim JY; Lee MS
Biochem Biophys Res Commun; 2019 Mar; 510(2):296-302. PubMed ID: 30686531
[TBL] [Abstract][Full Text] [Related]
17. Physalin D inhibits RANKL-induced osteoclastogenesis and bone loss via regulating calcium signaling.
Ding N; Lu Y; Cui H; Ma Q; Qiu D; Wei X; Dou C; Cao N
BMB Rep; 2020 Mar; 53(3):154-159. PubMed ID: 31964464
[TBL] [Abstract][Full Text] [Related]
18. The Study of Natural Compounds Targeting RANKL Signaling Pathway for the Treatment of Bone Diseases.
Liu C; He Y; Xu X; He L; He B; Kong L
Curr Drug Targets; 2020; 21(4):344-357. PubMed ID: 31566133
[TBL] [Abstract][Full Text] [Related]
19. DOK3 Modulates Bone Remodeling by Negatively Regulating Osteoclastogenesis and Positively Regulating Osteoblastogenesis.
Cai X; Xing J; Long CL; Peng Q; Humphrey MB
J Bone Miner Res; 2017 Nov; 32(11):2207-2218. PubMed ID: 28650106
[TBL] [Abstract][Full Text] [Related]
20. Stauntonia hexaphylla (Lardizabalaceae) leaf methanol extract inhibits osteoclastogenesis and bone resorption activity via proteasome-mediated degradation of c-Fos protein and suppression of NFATc1 expression.
Cheon YH; Baek JM; Park SH; Ahn SJ; Lee MS; Oh J; Kim JY
BMC Complement Altern Med; 2015 Aug; 15():280. PubMed ID: 26271279
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
